The Current Ratio as of November 2025 (TTM) for Gene Biotherapeutics, Inc. (CRXM) is 0.08

According to Gene Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.08. This represents a change of -40.44% compared to the average of 0.14 of the last 4 quarters.

Gene Biotherapeutics, Inc. (CRXM) Historical Current Ratio (quarterly & annually)

How has CRXM Current Ratio performed in the past?

The mean historical Current Ratio of Gene Biotherapeutics, Inc. over the last ten years is 0.80. The current 0.08 Current Ratio has changed 916.60% with respect to the historical average. Over the past ten years (40 quarters), CRXM's Current Ratio was at its highest in in the June 2012 quarter at 6.89. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Gene Biotherapeutics, Inc. (CRXM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Gene Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gene Biotherapeutics, Inc. (CRXM) Average Current Ratio

How has CRXM Current Ratio performed in the past?

The current Current Ratio of Gene Biotherapeutics, Inc. (CRXM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Gene Biotherapeutics, Inc. (CRXM) Current Ratio vs. Peers

How is CRXM’s Current Ratio compared to its peers?

Gene Biotherapeutics, Inc.’s Current Ratio is less than Gelesis Holdings, Inc. (0.46), less than NeonMind Biosciences Inc. (0.19), less than E-Qure Corp. (0.17), greater than GeneThera, Inc. (0.00), less than American CryoStem Corporation (0.12), greater than Capha Pharmaceuticals Inc. (0.01), less than Acacia Diversified Holdings, Inc. (0.08), greater than Generex Biotechnology Corporation (0.03), less than Navidea Biopharmaceuticals, Inc. (0.32), less than WPD Pharmaceuticals Inc. (0.10),

Build a custom stock screener for Gene Biotherapeutics, Inc. (CRXM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gene Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gene Biotherapeutics, Inc. (CRXM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gene Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.